Investors Appeal Dismissal Of Claims In Securities Class Action To 2nd Circuit
NEW YORK — Shareholders on July 25 filed a notice of appeal in a securities class action lawsuit against a pharmaceutical company and its former CEO, seeking Second Circuit U.S. Court...To view the full article, register now.
Already a subscriber? Click here to view full article